
Am J Psychiatry 2010; 167:24-39
(published online December 1, 2009; doi: 10.1176/appi.ajp.2009.09050744)
© 2010 American Psychiatric Association
The Interpersonal Dimension of Borderline Personality Disorder: Toward a Neuropeptide Model
Barbara Stanley, Ph.D., and
Larry J. Siever, M.D.
Borderline personality disorder is characterized by affective instability, impulsivity, identity diffusion, and interpersonal dysfunction. Perceived rejection and loss often serve as triggers to impulsive, suicidal, and self-injurious behavior, affective reactivity, and angry outbursts, suggesting that the attachment and affiliative system may be implicated in the disorder. Neuropeptides, including the opioids, oxytocin, and vasopressin, serve a crucial role in the regulation of affiliative behaviors and thus may be altered in borderline personality disorder. While clinical data are limited, the authors propose alternative neuropeptide models of borderline personality disorder and review relevant preclinical research supporting the role of altered neuropeptide function in this disorder in the hope of stimulating more basic research and the development of new treatment approaches.
This article has been cited by other articles:

|
 |

|
 |
 
A. S. New and B. Stanley
An Opioid Deficit in Borderline Personality Disorder: Self-Cutting, Substance Abuse, and Social Dysfunction
Am J Psychiatry,
August 1, 2010;
167(8):
882 - 885.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Reviews of Note
Journal Watch Psychiatry,
April 5, 2010;
2010(405):
3 - 3.
[Full Text]
|
 |
|

|
 |

|
 |
 
D. H. Angres
The Temperament and Character Inventory in Addiction Treatment
Focus,
April 1, 2010;
8(2):
187 - 198.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 2010
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|